Alx Oncology Holdings Inc
ALXO
Revenue
527.00k
▼-128.00k▼-19.54%
3 Months ChangeAssets
214.62M
▲1.97M▲0.9255%
3 Months ChangeLiabilities
55.30M
▲6.85M▲14.13%
3 Months ChangeFree Cash Flow
-38.07M
▼-9.57M▼-33.56%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-04
Form 8-K
ID: 0000950170-24-112734
2024-08-12
Form 10-Q
ID: 0000950170-24-095391
2024-08-08
Form 8-K
ID: 0000950170-24-093930
2024-08-06
Form 8-K
ID: 0000950170-24-091938
2024-06-17
Form 8-K
ID: 0000950170-24-074258
2024-05-09
Form 10-Q
ID: 0000950170-24-056953
2024-05-09
Form 8-K
ID: 0000950170-24-056886
2024-05-02
Form 8-K
ID: 0000950170-24-052093
2024-03-07
Form 8-K
ID: 0000950170-24-027925
2023-12-26
Form 8-K
ID: 0000950170-23-073016